for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Olympus Corp

7733.T

Latest Trade

2,476.50JPY

Change

3.00(+0.12%)

Volume

3,862,100

Today's Range

2,442.50

 - 

2,485.00

52 Week Range

1,883.50

 - 

2,741.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Olympus Corp - To Retire Treasury Shares Worth 5.22% Of Outstanding Stock On June 4

May 7 (Reuters) - Olympus Corp <7733.T>::OLYMPUS CORP - TO RETIRE TREASURY SHARES WORTH 5.22% OF OUTSTANDING STOCK ON JUNE 4.

Olympus Corp - Acquisition Of Quest Photonic Devices B.V. In Netherlands

Jan 28 (Reuters) - Olympus Corp <7733.T>::OLYMPUS CORP - NOTICE REGARDING ACQUISITION OF QUEST PHOTONIC DEVICES B.V. (TO MAKE IT A SUBSIDIARY) IN NETHERLANDS.

Olympus Says It Will Buy Veran Medical Technologies For $300 Mln

Dec 4 (Reuters) - Olympus Corp <7733.T>::NOTICE REGARDING ACQUISITION OF VERAN MEDICAL TECHNOLOGIES.ACQUISITION AMOUNT APPROX $300 MILLION.

Olympus Signing Of Definitive Agreement For Divestiture Of Imaging Business

Sept 30 (Reuters) - Olympus Corp <7733.T>::SIGNING OF DEFINITIVE AGREEMENT FOR DIVESTITURE OF IMAGING BUSINESS.

Olympus Corp - To Postpone Announcement Of Financial Forecasts For Fy2020/21Originally Scheduled For June 24

June 17 (Reuters) - Olympus Corp <7733.T>::OLYMPUS CORP - TO POSTPONE ANNOUNCEMENT OF FINANCIAL FORECASTS FOR FY2020/21ORIGINALLY SCHEDULED FOR JUNE 24.OLYMPUS CORP - AIM FOR FY2020/21 ANNUAL DIVIDEND AT SAME LEVEL AS PREVIOUS YEAR.

FDA Recommends Health Care Facilities, Manufacturers Transition To Duodenoscopes With Disposable Components

Aug 29 (Reuters) - FDA::FDA RECOMMENDS HEALTH CARE FACILITIES AND MANUFACTURERS BEGIN TRANSITIONING TO DUODENOSCOPES WITH DISPOSABLE COMPONENTS TO REDUCE RISK OF PATIENT INFECTION.FDA SAYS WARNS ABOUT CERTAIN TEST STRIPS ILLEGALLY MARKETED TO ASSESS DUODENOSCOPE CLEANLINESS.FDA SAYS ORDERS NEW POSTMARKET STUDIES FOR MANUFACTURERS, REQUESTS REAL-WORLD CONTAMINATION RATES IN DUODENOSCOPE LABELING.FDA SAYS CONTINUE TO WORK WITH MANUFACTURERS TO INCREASE SUPPLY OF DISPOSABLE CAP DUODENOSCOPES.FDA - RECOMMENDING HEALTH CARE FACILITIES TRANSITION AWAY FROM FIXED ENDCAP MODELS INCLUDING OLYMPUS CORPORATION'S TJF-Q160, TJF-Q180V, PJF-160 & JF-140F.FDA - RECOMMENDING HEALTH CARE FACILITIES TRANSITION FROM FIXED ENDCAP MODELS INCLUDING FUJIFILM MEDICAL SYSTEMS USA'S ED-530XT, PENTAX MEDICAL'S ED-3490TK.

Olympus Corp - Received Request From Individual Shareholder To Sue Auditor Kpmg Azsa Llc For 88.67 Billion Yen For Past Breach Of Duty

Olympus Corp <7733.T>::OLYMPUS CORP - RECEIVED REQUEST FROM INDIVIDUAL SHAREHOLDER TO SUE AUDITOR KPMG AZSA LLC FOR 88.67 BILLION YEN FOR PAST BREACH OF DUTY.

Olympus Corp - Announces 4-1 Stock Split

Olympus Corp <7733.T>::OLYMPUS CORP - ANNOUNCES 4-1 STOCK SPLIT.OLYMPUS CORP - STOCK SPLIT TO BE EFFECTIVE APRIL 1.

Olympus VP Yasuo Takeuchi To Be President And CEO From April 1

Jan 11 (Reuters) - Japan's Olympus Corp <7733.T>::VP YASUO TAKEUCHI TO BE PRESIDENT AND CEO FROM APRIL 1.TO FORMULATE A TRANSFORMATION PLAN AIMED AT BECOMING A GLOBAL MEDICAL TECHNOLOGY COMPANY.WILL STRENGTHEN SUPERVISING AND MONITORING FUNCTIONS OF THE BOARD BY APPOINTING NEW DIRECTORS WITH GLOBAL AND MULTILATERAL EXPERIENCE AND EXPERTISE.

Olympus Issues Statement Regarding U.S. DOJ Settlement

Dec 10 (Reuters) - Olympus Corp <7733.T>::OLYMPUS ISSUES STATEMENT REGARDING U.S. DEPARTMENT OF JUSTICE SETTLEMENT.OLYMPUS MEDICAL SYSTEMS CORPORATION SAYS SETTLEMENT DOES NOT IMPACT AVAILABILITY OF OLYMPUS PRODUCTS AND SERVICES WORLDWIDE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up